And you belong in the room as we tackle the most pivotal shift in life sciences: moving from AI that’s abstract to AI that drives impact.
Meet the pharma, biotech, and medtech leaders paving the way for AI adoption at scale across clinical research. Join your industry colleagues for a day of innovation in the heart of London.
Alistair Macdonald, Chief Executive Officer (CEO) for Worldwide Clinical Trials, brings a distinguished track record of leadership across the global healthcare and life sciences sectors. Most recently, he served as Operating Partner at GHO Capital Partners LLP, a premier healthcare-focused investment advisor. Prior to that, he was CEO of Syneos Health (formerly INC Research), a NASDAQ-listed global CRO. During his tenure, he led the company through transformative growth and operational integration, following a series of strategic mergers and global expansions.
Let’s meet at the event. Fill out the form, and we’ll be in touch.
Worldwide Clinical Trials welcomes you to our site. We collect information about your browsing experience such as cookies, pixels, and web beacons (collectively, “cookies”) to assist with improving your experience with our website. You may ‘Agree’ to accept categories of cookies or ‘Decline’ to reject optional cookies. Worldwide uses Essential Cookies, thus you may not opt of these Cookies as they are deployed to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For additional information on the categories of data we collect, the purposes for their collection, disclosures to third parties, and data retention, please visit our Privacy Policy or Cookie Notice for more information.